Pharmaids Pharmaceuticals Limited

BSE:524572 Stock Report

Market Cap: ₹2.0b

Pharmaids Pharmaceuticals Management

Management criteria checks 2/4

Pharmaids Pharmaceuticals' CEO is Prasad S., appointed in Jan 2024, has a tenure of less than a year. directly owns 1.21% of the company’s shares, worth ₹24.66M. The average tenure of the management team and the board of directors is 2.2 years and 2.2 years respectively.

Key information

Prasad S.

Chief executive officer

₹1.7m

Total compensation

CEO salary percentagen/a
CEO tenureless than a year
CEO ownership1.2%
Management average tenure2.2yrs
Board average tenure2.2yrs

Recent management updates

Recent updates


CEO

Prasad S. (48 yo)

less than a year

Tenure

₹1,704,000

Compensation

Dr. Prasad S. was the Group Chief of Strategy and Operational Excellence at Pharmaids Pharmaceuticals Limited and serves as its Chief Executive Officer since January 6, 2024. He has extensive expertise in...


Leadership Team

NamePositionTenureCompensationOwnership
Prasad S.
Chief Executive Officerless than a year₹1.70m1.21%
₹ 24.7m
B.C Balagangadhara
Chief Financial Officer2.2yrs₹3.20m1.84%
₹ 37.7m
Venu Kaparthy
Executive Director2.6yrs₹4.40m2.48%
₹ 50.8m
Mini Manikantan
Executive Director2.4yrs₹2.90m1.42%
₹ 29.0m
R. Bhavani
Accounts Officerno datano datano data
Ingreed Anisha
Assistant Manager of Admin & Purchaseno datano datano data
Prasanna Bhat
Company Secretary & Compliance Officerless than a yearno datano data

2.2yrs

Average Tenure

44yo

Average Age

Experienced Management: 524572's management team is considered experienced (2.2 years average tenure).


Board Members

NamePositionTenureCompensationOwnership
Venu Kaparthy
Executive Director2.6yrs₹4.40m2.48%
₹ 50.8m
Mini Manikantan
Executive Director2.4yrs₹2.90m1.42%
₹ 29.0m
Pattamadai Vijay
Independent Director2.2yrs₹500.00kno data
Mopperthy Anand
Non-Executive Independent Director18.8yrsno datano data
Shankarappa Nagaraj Babu
Non Executive Non Independent Chairman of the Boardless than a yearno data14.74%
₹ 301.6m
Methuku Nagesh
Independent Non-Executive Director2.1yrs₹500.00kno data
Shreedhara Shetty
Non-Executive & Non-Independent Director1.3yrsno data17.69%
₹ 361.9m

2.2yrs

Average Tenure

55yo

Average Age

Experienced Board: 524572's board of directors are not considered experienced ( 2.2 years average tenure), which suggests a new board.


Company Analysis and Financial Data Status

DataLast Updated (UTC time)
Company Analysis2024/12/24 05:14
End of Day Share Price 2024/12/24 00:00
Earnings2024/09/30
Annual Earnings2024/03/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

PackageDataTimeframeExample US Source *
Company Financials10 years
  • Income statement
  • Cash flow statement
  • Balance sheet
Analyst Consensus Estimates+3 years
  • Forecast financials
  • Analyst price targets
Market Prices30 years
  • Stock prices
  • Dividends, Splits and Actions
Ownership10 years
  • Top shareholders
  • Insider trading
Management10 years
  • Leadership team
  • Board of directors
Key Developments10 years
  • Company announcements

* example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .

Analyst Sources

Pharmaids Pharmaceuticals Limited is covered by 0 analysts. 0 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

AnalystInstitution